Related by context. All words. (Click for frequent words.) 68 subpopulations 63 subgroup 57 subgroups 57 somatic mutations 56 EGFR mutations 55 IPAH 55 KRAS mutation 55 phenotypic characteristics 55 HCCs 55 genetic polymorphisms 55 KRAS mutations 55 ZNF# 55 prostate cancer CaP 55 K ras mutations 55 hepatocellular carcinomas 55 histological subtype 55 phenotype 55 mutated K ras 54 renal tumors 54 EGFR mutation 54 phenotypically 54 heterozygotes 54 subset 54 heavily pretreated 54 germline mutations 54 K ras mutation 54 lymphocyte 54 K ras 54 CD# + [002] 54 cTnI 54 EBV infection 54 BRAF mutation 53 S. maltophilia 53 immunocompetent 53 EGFR mutation positive 53 missense mutations 53 prospectively defined 53 HbF 53 gastric carcinoma 53 malignant nodules 53 HIV HCV coinfected 53 ovarian carcinoma 53 allelic variants 53 cervical lymph nodes 53 prostate carcinoma 53 isotype 53 TGFBR1 * 6A 53 seminomas 53 HER2 expression 53 subsets 53 telomere lengths 53 molecular subtypes 53 breast carcinomas 53 immunoreactivity 53 chromosomal alterations 52 ADPKD 52 sporadic ALS 52 BDNF protein 52 subfamily 52 haplotype 52 supratentorial 52 karyotypes 52 GISTs 52 carcinoid 52 cellularity 52 adverse cytogenetics 52 functional polymorphism 52 adenocarcinomas 52 mutant allele 52 allele frequencies 52 splice variants 52 CGG repeats 52 heterozygous 52 virological response 52 MYCN amplification 52 subtypes 52 deleterious mutation 52 T1a 52 membrane proximal 52 rs# [004] 52 medulloblastomas 52 ERK signaling 52 chromosome #q#.# [001] 52 genetic heterogeneity 52 poorer prognosis 52 PBMCs 52 populations 52 NNRTI resistance 52 microdeletion 52 Xenopus 52 haplogroups 52 p# biomarker 52 uPAR 52 subtype 52 prognostic indicators 52 periprocedural MI 52 haplotypes 52 mutant BRAF 52 histologic subtype 52 differentially expressed genes 52 clade B 52 microglial 52 mTOR inhibitors 51 orthologs 51 GBM tumors 51 causative mutation 51 homozygotes 51 BCR ABL mutations 51 stratifying patients 51 Estrogen Receptor 51 prognostically 51 systolic dysfunction 51 K ras gene 51 MAPK pathway 51 liver metastases 51 myeloproliferative diseases 51 IgA deficiency 51 clades 51 KRAS gene 51 normal karyotype 51 prion infection 51 phenotypic expression 51 NSCLC tumors 51 morphologically 51 tumor histology 51 prognostic markers 51 susceptibility genes 51 TOP2A 51 oligodendroglioma 51 lymphoid cells 51 PNH patients 51 perioperative complications 51 brucei 51 IDH1 mutation 51 chromosomal rearrangement 51 N Myc 51 NPM1 mutations 51 CD8 + 51 indolent lymphomas 51 null mice 51 hamartomas 51 antibody titer 51 CD#c 51 cerebellar vermis 51 genotype 51 hepatoma 51 miRNA expression 51 activin 51 kinase inhibition 51 KLF4 51 pheochromocytoma 51 penetrance 51 baseline LDH 51 apoE4 51 monogenic 51 beta globin gene 51 histologies 51 Li Fraumeni 51 renal cell carcinomas 51 neuroblastomas 51 breast cancer subtypes 51 neutralizing antibody 51 homozygosity 51 colonic mucosa 51 nondemented 51 mutant alleles 51 chromosome #q# [002] 51 EGFR expression 51 transcriptomes 51 proteomes 51 T2DM 51 coinfection 51 syngeneic 51 EGFR activating mutations 51 differential gene expression 51 CYP#D# genotype 51 neoplasm 51 serologically 51 hyperplastic 51 granulocytes 51 epitope 51 metaplasia 51 isoform 51 karyotype 50 APOE e4 50 null responder 50 CSF biomarkers 50 HNSCC 50 subgroup analyzes 50 underwent resection 50 Rab# 50 CpG 50 chromosomal regions 50 mesotheliomas 50 pulmonary nodules 50 innervation 50 HBeAg positive 50 alleles 50 FLT3 50 gene polymorphism 50 glioblastoma tumors 50 coexpression 50 tumorigenicity 50 operable breast cancer 50 ependymomas 50 chemokine receptor 50 completely resected 50 gastric carcinogenesis 50 de novo mutations 50 unfavorable cytogenetics 50 clinicopathological features 50 histologic 50 VEGF expression 50 Leydig cell 50 ethnically diverse populations 50 maternally inherited 50 tumor biopsies 50 EBNA1 50 neuroblastoma tumors 50 gene locus 50 circulating endothelial cells 50 efficacy evaluable 50 achieved sustained virological 50 C1q 50 prognostic marker 50 CD# expression [002] 50 elevated triglyceride levels 50 CC genotype 50 SNP rs# [002] 50 cortices 50 umbilical vein 50 GBMs 50 cAMP signaling 50 hyperoxaluria 50 endophenotypes 50 squamous cell lung cancer 50 CD# + [001] 50 ependymoma 50 genomic alterations 50 HLA genes 50 mutated KRAS gene 50 promoter methylation 50 castrate resistant 50 immunologically 50 papillary renal cell carcinoma 50 observational cohort study 50 relapsed AML 50 molecularly defined 50 carotid plaques 50 BRCA mutation carriers 50 PCa 50 LRP6 50 prognostic biomarker 50 indel 50 morphologically distinct 50 epigenetically 50 coronary stenosis 50 granulocyte 50 mCRC patients 50 liver transplant recipients 50 etiologic 50 diagnostic biomarker 50 gene expression profiles 50 mRNA expression 50 metastatic lymph nodes 50 histologic subtypes 50 urothelial carcinoma 50 #q#.# [001] 50 atheroma volume 50 CD# expression [001] 50 carotid plaque 50 phylogenetically 50 elevated LDH 50 sequence homology 50 carcinoids 50 gene loci 50 Peromyscus 50 EGFR mutation status 50 underlying pathophysiology 50 methylation patterns 50 docetaxel pretreated 50 TMPRSS2 ERG fusion 50 genomically 50 inhibitory receptor 49 colorectal tumors 49 erythrocytes 49 HepG2 cells 49 M. pneumoniae 49 druggable targets 49 miRNA genes 49 lymphoblastoid cell lines 49 PTEN gene 49 HPV subtypes 49 hyperplastic polyps 49 nodal metastasis 49 S#A# [002] 49 germline mutation 49 #q# deletion 49 chemoresistant 49 proband 49 genetic abnormality 49 prepubertal 49 microdeletions 49 distinct subtypes 49 thyroid carcinoma 49 circulating EPCs 49 de novo AML 49 PARP inhibition 49 FGFR2 49 genetic loci 49 lymphocyte counts 49 hematopoietic cells 49 seropositivity 49 liver histology 49 MYH9 gene 49 familial clustering 49 NKT cells 49 immunoregulatory 49 socioeconomic status SES 49 epithelial tumors 49 exomes 49 humoral responses 49 clinicopathologic 49 homodimers 49 PITX2 49 lymph node involvement 49 hematopoietic cancers 49 micrometastases 49 causal variants 49 microRNA expression 49 prognostic variables 49 dysregulated 49 monozygotic twins 49 plasma pharmacokinetics 49 FDG uptake 49 T#I [002] 49 mononuclear cells 49 chronicity 49 chronic HBV infection 49 exon 49 prognostic indicator 49 HER2 positive cancers 49 CYP#B# 49 neutrophil counts 49 histological subtypes 49 tertile 49 mRNA transcripts 49 cardiac progenitor cells 49 pT2 49 ischemic lesions 49 Immunohistochemical analysis 49 proinflammatory cytokine 49 PKD1 49 Neisseria 49 genes predisposing 49 phenotypic variation 49 osteopenic 49 autosomal recessive disease 49 FGFs 49 #p# [001] 49 nodal metastases 49 thyroid nodules 49 breast carcinoma 49 prostate cancer PCa 49 Asymptomatic 49 KRAS status 49 demyelinating 49 cytogenetic abnormalities 49 cutaneous lesions 49 hyper IgE syndrome 49 seronegative 49 BRCA1 mutations 49 esophageal squamous cell carcinoma 49 genotypic 49 gastric adenocarcinoma 49 chromosome #p# [001] 49 IDH mutations 49 pancreatic tissue 49 angiographically 49 myeloid progenitors 49 BCL#A 49 HER2 overexpression 49 splenectomized patients 49 monophyletic 49 predictive biomarker 49 Subgroups 49 transcriptional activation 49 HBeAg negative 49 PTPN# 49 normotensive 49 HGPS 49 TMEM#B 49 p# mutation 49 tumor subtypes 49 eIF 4E 49 Prognostic factors 49 polymorphisms 49 extramedullary 49 clonogenic 49 baseline CD4 49 spontaneous mutations 49 pT3 49 androgen deprivation 49 genotypes 49 dizygotic twins 49 mediated inhibition 49 Gleevec resistant 49 genetic determinants 49 biochemical abnormalities 49 HLA DR 49 PKCi 49 variant allele 49 neurona 48 metastatic lesion 48 lymphocytosis 48 ConclusionThis 48 pCR 48 PCNSL 48 genetic polymorphism 48 LTBI 48 colorectal tumor 48 mouse testes 48 lateral ventricle 48 microRNA miR 48 molecular abnormalities 48 PGCs 48 haematopoietic 48 corticosterone levels 48 elevated CRP 48 sarcomatoid 48 serum concentrations 48 sexually dimorphic 48 antibody titers 48 pretreatment serum 48 lymphoid 48 Histologically 48 mutational status 48 ApoE4 48 androgen receptor AR 48 gene rearrangements 48 amino acid residues 48 mammary stem cells 48 xenograft models 48 IGF1 48 haplogroup 48 histologically 48 epigenetic mechanisms 48 CagA 48 Brugada syndrome 48 globin genes 48 aneuploid cells 48 chronic periodontitis 48 pleiotropic effects 48 immunodeficient 48 candidemia 48 Castorocauda 48 downstream effectors 48 etiologic factors 48 etiologic agent 48 myeloid 48 IFN gamma 48 Supplementary Fig 48 ERBB2 48 bladder carcinoma 48 PKM2 48 chromosomal anomalies 48 BRCA2 mutation 48 metabolic abnormalities 48 Genotypes 48 polymorphism 48 infarcts 48 beta1 integrin 48 deletion 5q 48 GSTM1 48 endogenous retroviruses 48 ASCUS 48 pancreatic islet 48 pDCs 48 multivariate analyzes 48 SLC#A# [002] 48 #q# [001] 48 perivascular 48 EGFR blockers 48 allele 48 parasitaemia 48 prognostic significance 48 schwannomas 48 meningiomas 48 OGG1 48 EGF receptors 48 retrospective cohort 48 ovariectomized 48 genes CYP#C# 48 nonsmall cell lung cancer 48 HBV infected 48 HBsAg 48 acute leukemias 48 Subgroup analysis 48 synuclein 48 prognostic factors 48 TIMP 48 transaminase levels 48 VKORC1 48 genotyped 48 PECAM 1 48 KIT mutations 48 mosaicism 48 Notch receptor 48 activating mutations 48 neoplastic cells 48 HLA DR4 48 apolipoprotein E gene 48 CNVs 48 HERV 48 neurodevelopmental outcome 48 immunohistochemical staining 48 Leukemias 48 Hp2 2 48 BMPR2 48 morphologic 48 hemoglobin concentration 48 estrogen receptor ER 48 cathepsins 48 myopathies 48 prespecified 48 granulosa cell 48 chromosome rearrangements 48 pancreatic adenocarcinoma 48 microRNA molecules 48 advanced neoplasia 48 familial ALS 48 transmembrane protein 48 genetically distinct 48 missense mutation 48 squamous histology 48 basal cell nevus syndrome 48 isotypes 48 TCF#L# 48 multivariate Cox 48 PON1 48 airway hyperresponsiveness 48 Sjögren syndrome 48 EoE 48 CD# CD# 48 Protein Kinase C 48 clinically evaluable 48 serologic 48 tigecycline 48 monocytic 48 T1DM 48 phthalate syndrome 48 HBV genotypes 48 evolutionarily conserved 48 outbred 48 pulmonary metastases 48 miR #a [001] 48 melanocytic nevi 48 HSCT 48 adenoma 48 antibody mediated 48 HLA DQ2 48 cytoplasmic domain 48 FMR1 48 non coding RNA 48 human leukocyte antigen 48 laterality 48 narcolepsy cataplexy 48 OPRM1 48 B7 H3 48 retinal neurons 48 lung carcinomas 48 LRRK2 mutation 48 HIV seronegative 48 phenotypic differences 48 vestibular schwannomas 48 TT genotype 48 BRAF V#E 48 virologic failure 48 amyloid peptide 48 kidney allograft 48 mutant protein 48 GPNMB 48 acute myeloid 48 HLA B# 48 aneuploidies 48 allele frequency 48 Immune responses 48 GIST tumors 48 mucinous 48 phosphatases 48 squamous cell histology 48 clonal expansion 48 metalloprotease 48 MDSCs 48 hepatitis C genotype 48 CXCR4 48 LVNC 48 flavopiridol 48 p# Shc 48 NAbs 48 subconjunctival hemorrhage 48 serum HBV DNA 48 rat hepatocytes 48 cynomolgus macaques 48 SSc 48 biochemical marker 48 splice junctions 48 shortened telomeres 48 locoregional 48 serous ovarian cancer 48 subfamilies 48 overexpression 48 quasispecies 48 HLA DRB1 48 MTHFR 48 FLT3 mutations 48 precursor lesions 48 COL#A# 47 perilipin 47 coronary stenoses 47 phylogeographic 47 Alleles 47 recurrent VTE 47 fibrosis progression 47 Borrelia 47 tyrosine phosphorylation 47 T. vaginalis 47 vermis 47 malignant neoplasm 47 epithelia 47 transgene expression 47 EGFRvIII 47 monocyte 47 gene expression patterns 47 neoplastic lesions 47 Kaplan Meier analysis 47 albicans 47 JAK2 mutation 47 bone marrow stromal cells 47 Vpu 47 aT cell 47 N. gonorrhoeae 47 Cytotoxic T 47 nondepressed 47 phosphate S1P 47 downregulation 47 NKX#.# 47 Histologic 47 subadult 47 blastomeres 47 postoperative radiotherapy 47 subclinical hypothyroidism 47 Bacteroides 47 orchitis 47 bacterial genomes 47 pharmacodynamic endpoints 47 HER2 receptor 47 gene deletions 47 cTnT 47 antiphospholipid antibodies 47 mutation 47 genes differentially expressed 47 serum creatinine levels 47 pg ml 47 MSH2 47 virologic response 47 elevated triglycerides 47 MHC genes 47 comorbid disorders 47 Multivariate analyzes 47 deleterious mutations 47 SPINK1 47 lymphoma subtypes 47 antibody responses 47 survivin 47 homologs 47 ependymal cells 47 serum urate levels 47 serum leptin 47 locoregional recurrence 47 distal colon cancer 47 virulence genes 47 pancreatic endocrine 47 del 5q 47 Fas ligand 47 T1D 47 immunized mice 47 CP CPPS 47 Lymphocytes 47 cyclin E 47 cytochrome b 47 TMPRSS2 ERG 47 extracapsular extension 47 serogroup 47 multivessel disease 47 exocrine pancreas 47 malignant lesions 47 constitutively expressed 47 body louse genome 47 nonmetastatic 47 extracellular domain 47 KRAS wild 47 immunopathology 47 HCV replicon 47 C#BL 6 mice 47 Hsp# [001] 47 vivax 47 monomorphic 47 MMSE scores 47 maturational 47 microsatellite markers 47 P. falciparum 47 genotypic resistance 47 oncologic outcomes 47 JAK2 V#F 47 LV dysfunction 47 mtDNA mutations 47 fluoroquinolone resistance 47 seroprevalence 47 dyslipidaemia 47 ncRNAs 47 K#R [002] 47 IFN γ 47 transthyretin amyloidosis 47 neovascular glaucoma 47 Leydig cells 47 epithelial ovarian cancer 47 gefitinib 47 antiangiogenic therapy 47 ABCB1 47 mice lacking 47 Hurthle cell 47 bronchial epithelial cells 47 complete cytogenetic response 47 antithrombotic agents 47 capsular polysaccharide 47 lysosomal storage disease 47 genes encoding 47 decompensated liver disease 47 taxane therapy 47 pomalidomide 47 lymph node metastasis 47 FMR1 gene 47 GBA mutations 47 CHD5 47 intracellular bacteria 47 Cytogenetic 47 CD8 responses 47 oral squamous cell 47 quantitative RT PCR 47 amino acid substitution 47 arterial thickening 47 T2 lesions 47 adnexal mass 47 macroalbuminuria 47 SNP rs# [001] 47 lung adenocarcinomas 47 intergenic 47 DRB1 * 47 histocompatibility 47 circadian genes 47 LV hypertrophy 47 underdiagnosis 47 Li Fraumeni syndrome 47 ApoE gene 47 microsatellite instability 47 chemokine receptors 47 advanced adenomas 47 Prox1 47 clinicopathological 47 Multivariate analysis 47 subcellular compartments 47 phylogenetic analyzes 47 Mus musculus 47 attain statistical significance 47 autoantibody 47 proto oncogene 47 microsatellite loci 47 aminotransferase levels 47 genetic locus 47 hyperactivation 47 genetic variation 47 TTR gene 47 intracranial hemorrhage ICH 47 CR nPR 47 paroxysmal AF 47 poor metabolizers 47 perfusion abnormalities 47 microfilariae 47 nucleotide sequence 47 genetic relatedness 47 serum folate concentrations 47 grade cervical intraepithelial 47 tumor subtype 47 Mycoplasma pneumoniae 47 latent tuberculosis infection 47 VNTR 47 genotype 1a 47 HLA A2 47 TP# mutation 47 lymphocytic 47 interindividual variability 47 atypical hyperplasia 47 CHD7 47 peptide antigens 47 MC1R gene 47 biochemical recurrence 47 PI3 kinase 47 susceptibility loci 47 pathologic 47 mCRPC 47 SLNB 47 telomere length 47 GH deficiency 47 curative therapy 47 KCNH2 47 peripheral blood mononuclear 47 EGFR tyrosine kinase inhibitors 47 microcephalin 47 MLL2 47 urine cytology 47 Supplementary Table 47 ultraconserved elements 47 epithelioid 47 virologic responses 47 C#Y 47 clade 47 node metastases 47 heterozygote 47 definite stent thrombosis 47 metastatic prostate 47 immunostaining 47 neurological manifestations 47 allelic variation 47 FGFR1 47 bone marrow mesenchymal stem 47 thyroid nodule 47 Clusterin 47 induced sputum 47 histone modifications 47 kidney transplant recipients 47 paraganglioma 47 hepatic fibrosis 47 adenomatous polyps 47 obstructive coronary artery 47 lactase persistence 47 transcriptome 47 noncardiac 47 aminotransferase 47 suicide attempters 47 metabolomic profiles 47 fractional anisotropy 47 amyloid cascade 47 rCBF 47 VHL gene 47 genetic mutation 47 squamous 47 CEACAM1 47 leucopenia 47 chromosome #q# [001] 47 Kaplan Meier curves 47 malignant prostate 47 hypermethylated 47 CCR7 47 initiating antiretroviral therapy 47 HDAC3 47 adiponectin concentrations 47 Her2/neu 47 small lymphocytic lymphoma 47 intron 47 nonmelanoma skin cancers 46 VSMCs 46 lymphadenectomy 46 radioimmunotherapy RIT 46 #p# [003] 46 lymphovascular invasion 46 serum albumin 46 rituximab monotherapy 46 CTEPH 46 gene polymorphisms 46 dosing cohort 46 metastatic malignant melanoma 46 pilocytic astrocytomas 46 hyperhomocysteinemia 46 TAXUS IV 46 comorbid conditions 46 HBeAg 46 baseline HbA1c 46 colorectal neoplasms 46 DNA methylation patterns 46 substudy 46 anaerobes 46 DNA rearrangements 46 segmental duplications 46 lymphoid tumors 46 M#V mutation 46 tNOX 46 B lymphocytes 46 mitochondrial DNA mutations 46 lymphoproliferative disorder 46 Haplotype 46 stage IIIB 46 homozygous 46 BARD1 46 cathepsin B 46 plasmacytoid 46 pDC 46 renal cysts 46 loci 46 hippocampal volumes 46 autoregulation 46 cysteines 46 psychiatric comorbidity 46 Non inferiority 46 TLE3 46 mPFC 46 colorectal neoplasia 46 tropism 46 multivariable analysis 46 CYP#C# gene 46 Eg5 46 familial pancreatic cancer 46 HIV coinfected 46 serum lipid levels 46 nasopharyngeal carcinoma 46 hippocampi 46 thiopurine 46 radical nephrectomy 46 MTHFR gene 46 trabecular bone 46 metazoan 46 vitellogenin 46 leptin receptor 46 intravesical therapy 46 mononuclear 46 ErbB2 positive 46 imatinib resistance 46 CDKN2A 46 GLUT1 46 HCMV 46 siRNAs targeting 46 histone deacetylases 46 SORT OUT III 46 subcortical 46 histologically confirmed 46 HCV infected 46 metastatic neuroendocrine tumors 46 cytopathic 46 NR#A# 46 β1 46 ± SEM 46 APOE genotype 46 Genetic variation 46 parietal regions 46 probands 46 catechol O methyltransferase 46 GPC5 46 Xenopus laevis 46 mitochondrial mutations 46 P cadherin 46 ERK2 46 LHRH receptor positive 46 phenotypes 46 Th1 46 IKZF1 46 mutations 46 independent prognostic marker 46 microbleeds 46 S/GSK# 46 PrPSc 46 CNTNAP2 46 somites 46 WNK1 46 SVZ 46 logistic regression analysis 46 ABL kinase 46 nucleoside naive 46 isolated systolic hypertension 46 WT1 46 IGF IR 46 polypoid lesions 46 cytogenetic 46 acute myelogenous leukemia AML 46 neoadjuvant 46 nucleotide substitutions 46 isoforms 46 H. pylori eradication 46 trans retinoic acid 46 LDL particle 46 NNRTI resistant virus 46 epitopes 46 apoE 46 MMSE score 46 p# MAPK 46 HCV genotype 46 claudin 46 oncogenic HPV types 46 autoantigen 46 C. albicans